Tom Nicholson, B.A., MIDP - specializes in designing and launching strategic initiatives in global health, with a focus on projects built on solidarity, mutual assistance, and eliminating causes of early death and injury. He holds an appointment as Associate in Research at the Duke Center for International Development (DCID), at the Sanford School of Public Policy at Duke University, with a focus on equity, supply chain integration, and policy innovation in the global response to drug-resistant tuberculosis (TB). His publications focus on human rights and health, mutual aid, and integrated health systems.

Nicholson serves on the Board of Directors for the Global Health Council in Washington DC, the preeminent global health association in the United States, representing thousands of organizations who set policy and implement global health programs. He serves on the audit committee and is vice-chair of the membership and development committee.

He is an Expert on Mission from the United Nations, in their Office for Project Services, serving as international technical consultant (ICAIII). In this capacity, he travels to India, Ukraine, and other countries advising governments and partners on health delivery program strengthening. Nicholson co-founded and is Executive Director of Advance Access & Delivery (AA&D), a global NGO focused on health care delivery in challenging settings, which is the secretariat of the Zero TB Initiative and Zero TB Cities Project. AA&D has projects and partners in six countries providing health care delivery for diabetes, hypertension, tuberculosis, and HIV. Nicholson worked for 9 years for Partners In Health, and while there he was a Project Director for a 5-year population health grant from Doris Duke Charitable Foundation’s African Health Initiative (AHI) to Brigham and Women’s Hospital, Partners in Health, Harvard Medical School, the National University of Rwanda - School of Public Health, and the Rwandan Ministry of Health. This project recorded some of the most rapid declines in infant and maternal mortality ever rigorously recorded. Prior to this, he managed and coordinated international multidrug-resistant tuberculosis projects in the Russian Federation and the former Soviet Union with Partners on Health and has been involved in global TB policy discussions since 2005. He holds a Master of International Development Policy (MIDP) from Duke University’s Sanford School of Public Policy and a BA in Political Science from Indiana University - Bloomington. He was a Visiting Research Fellow at Harvard Medical School in 2013.

Salmaan Keshavjee, M.D. Ph. D. is a leading expert in tuberculosis treatment and the anthropology of health policy. He is the author of Blind Spot: How neoliberalism infiltrated global health­. He has worked extensively with the Boston-based non-profit Partners In Health (PIH) on the treatment of multidrug-resistant tuberculosis (MDR-TB). Over the last 20 years, Dr. Keshavjee has conducted clinical and implementation research on MDR-TB in Russia, both in the prison and civilian sectors. He was Deputy-Director for the Partners In Health’s health programs in Lesotho (2006-2008), launching one of the first community-based treatment programs for multi-drug resistant tuberculosis/HIV co-infection in sub-Saharan Africa. His research has resulted in a number of clinical and policy manuscripts on TB and MDR-TB, which have had significant clinical and policy impact.

Dr. Keshavjee is the Chair of the Steering Committee for the Zero TB Initiative, a global coalition of implementers, policy makers and activists working to create islands of tuberculosis elimination in a number of countries worldwide. He was the Chair of the World Health Organization/Stop TB Partnership’s Green Light Committee for Multidrug-resistant TB from 2007-2010. He has been involved in a number of global guidelines for tuberculosis treatment including at the World Health Organization and the American Thoracic Society.

Jason R. Sanders, MD, MBA is the Senior Vice President and Provost of the University of Oklahoma Health Sciences Center, with overall responsibility for its seven colleges and clinical, educational, and research programs, including OU Physicians and the Stephenson Cancer and Harold Hamm Diabetes Centers. He also serves as Vice Chair of the OU Medicine Health System, and on the the University Hospitals Authority and Trust Board, with a focus on integration across the healthcare delivery system. Dr. Sanders provides patient care in Internal Medicine at OU Physicians and OU Medical Center. He teaches medical students and residents, as well as courses in inter-professional practice, literature and medicine, and the business of medicine. He is a member of the Dean McGee Eye Institute Board, Greater Oklahoma City Chamber Board, Oklahoma City Innovation District Board, United Way Board, Children’s Hospital Foundation Advisory Board, Stephenson Cancer Center Leadership Council, Price College of Business MBA Advisory Board, and American Association of Medical Colleges (AAMC) Medical Center Leaders Caucus. Dr. Sanders graduated with honors in biochemistry from the University of Oklahoma, studied English at Trinity College, Oxford as a Rhodes Scholar, and graduated from Harvard Medical School and Harvard Business School with distinction as Harvard’s first combined MD/MBA program graduate. He completed residency training in Internal Medicine at the Massachusetts General Hospital, including projects in population health and care redesign, and worked in the private sector with major payors, hospitals, and pharmaceutical companies as a consultant with McKinsey & Company.